The report says consolidated revenue could rise ~167% YoY on the acquired Imperial Blue portfolio, but adjusted EBITDA margin may contract ~90bps to 14.2% and adjusted PAT decline 9% YoY to INR482mn due to interest costs of about INR650mn.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
421 notes from HDFC Securities · 01 Oct 2026, 00:00 to 01 Nov 2026, 00:00 IST
The note says Radico is expected to lead the coverage with ~13% revenue growth, 44% EBITDA growth and ~59% adjusted PAT growth in Q2FY27E, aided by ~30% P&A growth and a 45% rise in Magic Moments vodka, with EBITDA margin held above 20%.
Read this note →The report estimates +2.3% QoQ CC growth for Happiest Minds and cuts its target price from INR 400 to INR 360.
Read this note →The note expects Mastek to grow +1.7% QoQ CC and cuts its target price from INR 2,080 to INR 1,920 on a lower 12x multiple.
Read this note →The report calls Sonata a key laggard at +0.6% QoQ CC on slow ramp-up and cuts its target price from INR 360 to INR 340 while retaining BUY.
Read this note →The note downgrades Birlasoft from BUY to ADD and cuts the target price to INR 365, flagging it as a key laggard at +1.0% QoQ CC on a slow turnaround.
Read this note →The report names Zensar among its preferred smaller names and expects +2.4% QoQ CC growth, while cutting the target price from INR 600 to INR 565.
Read this note →The note upgrades Cyient to BUY with target price raised from INR 1,350 to INR 1,450, expecting DET growth of +5.5% QoQ CC including one month of Tao Digital consolidation.
Read this note →The report estimates +1.7% QoQ CC growth for Tata Elxsi and cuts its target price from INR 4,100 to INR 3,900 on a lower 25x multiple.
Read this note →The note expects LTTS to grow +2.1% QoQ CC and aim for mid-single-digit FY27E growth, with target price raised to INR 3,570.
Read this note →The report expects Mphasis to grow +3.5% QoQ CC on continued BFSI ramp-up and names it a mid-tier preference, raising the target price to INR 2,840.
Read this note →The note says Persistent will lead mid-tier growth at +6.3% QoQ CC including the Concise Systems acquisition, and is a stated mid-tier preference, with target price raised to INR 6,070.
Read this note →The report lists LTIMindtree as a mid-tier preference and expects +5.3% QoQ CC growth aided by about one month of Randstad IT consolidation (organic ~+0.6%), with target price raised from INR 5,000 to INR 5,270.
Read this note →The note says Tech Mahindra will post one of the best tier-1 prints at +0.9% QoQ CC, tier-1-leading +5.3% YoY CC growth and ~190bps YoY margin expansion, with target price raised to INR 1,660.
Read this note →The report expects Wipro's revenue to decline -0.4% QoQ CC and guidance of -1% to 0% QoQ CC for Q3FY27E factoring furloughs, with target price cut from INR 195 to INR 185.
Read this note →The note expects HCL Tech to lead tier-1 at +2.0% QoQ CC with ~50bps margin expansion, while trimming the upper end of its services guidance to 1.5-3%, and raises the target price to INR 1,370.
Read this note →The report says Infosys is its preferred tier-1 pick but expects +1.3% QoQ CC growth, a 50bps FY27E guidance cut to 2-3% CC, TCV of about USD 2-3bn, and a target price trimmed from INR 1,300 to INR 1,250.
Read this note →The note says TCS will trail expectations in a seasonally strong quarter at +0.5% QoQ CC, with TCV of USD 8-10bn and a maintained 26-28% margin band, and its target price is cut from INR 2,580 to INR 2,470 on a lower 15x multiple.
Read this note →The note says it estimates a ~7% EBITDA impact for Aster DM and maintains BUY.
Read this note →The note says it estimates a ~6% EBITDA impact for Max Healthcare and maintains BUY.
Read this note →The note says it estimates a ~5% EBITDA impact for Apollo Hospital under the assumed margin-cap scenario and maintains a BUY rating.
Read this note →